Ani Pharmaceuticals (ANIP) Net Cash Flow (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Net Cash Flow of $25.4 million for Q1 2026, up 4.55% sequentially from $24.3 million in Q4 2025, and up 385.49% YoY from $5.2 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Net Cash Flow (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at $25.4 million in Q1 2026.
- Quarterly Net Cash Flow rose 385.49% year-over-year to $25.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.2 million (up 306.63% YoY) and the FY2025 annual result came in at $141.0 million, up 286.07% from the prior year.
- Net Cash Flow grew to $25.4 million in Q1 2026 per ANIP's latest filing, from $24.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $94.0 million in Q2 2023 and troughed at -$95.0 million in Q3 2024.
- A 5-year average of $12.1 million and a median of $11.5 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow plunged 1567.69% in 2022, then surged 8844.12% in 2025.
- Over 5 years, Net Cash Flow stood at -$8.0 million in 2022, then jumped by 448.36% to $28.0 million in 2023, then plunged by 99.03% to $272000.0 in 2024, then soared by 8844.12% to $24.3 million in 2025, then climbed by 4.55% to $25.4 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $25.4 million, $24.3 million, and $44.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 48.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.97 Mn |
| Jun 30, 2026 | 48.97 Mn |
| Mar 31, 2026 | 25.44 Mn |
| Mar 31, 2026 | 25.44 Mn |
| Dec 31, 2025 | 24.33 Mn |
| Dec 31, 2025 | 24.33 Mn |
| Sep 30, 2025 | 44.24 Mn |
| Sep 30, 2025 | 44.24 Mn |
| Jun 30, 2025 | 67.16 Mn |
| Jun 30, 2025 | 67.16 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | 272,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | -95.02 Mn |
| Sep 30, 2024 | -95.02 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Mar 31, 2024 | 7.48 Mn |